Mastering Medical
USMLE Step 2 CK · Respiratory

Idiopathic pulmonary fibrosis vs Hypersensitivity pneumonitis

How to tell Idiopathic pulmonary fibrosis and Hypersensitivity pneumonitis apart when a board question makes them look alike.

Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.

Fastest separator

Clear antigen exposure history with BAL lymphocytosis favors hypersensitivity pneumonitis over idiopathic pulmonary fibrosis.

Side by side

Idiopathic pulmonary fibrosisHypersensitivity pneumonitis
Key clue

Progressive exertional dyspnea with bibasilar crackles and usual interstitial pneumonia pattern on HRCT indicates idiopathic pulmonary fibrosis.

Dyspnea and cough linked to bird or mold exposure with centrilobular nodules and ground-glass opacities suggests hypersensitivity pneumonitis.

Mechanism

Repeated epithelial injury leads to fibroblast activation and irreversible interstitial fibrosis with honeycombing.

Inhaled organic antigens trigger immune-mediated alveolar inflammation that may improve with antigen removal and corticosteroids.

Labs and tests

HRCT shows basal and subpleural reticulation with honeycombing and traction bronchiectasis, PFT shows restrictive defect with reduced DLCO, and BAL is not lymphocyte-predominant.

HP often shows exposure history, HRCT with upper or mid-lung ground-glass and centrilobular nodules, BAL lymphocytosis above 20%, and precipitating IgG antibodies to culprit antigen.

The trap

Both diseases can show restrictive physiology, so clinicians overcall IPF in exposed patients. The resolving clue is exposure-linked symptom fluctuation plus inflammatory imaging pattern rather than basal honeycombing.

The repair move

Next best step: remove ongoing antigen exposure immediately and start oral prednisone 0.5 mg/kg/day for symptomatic subacute hypersensitivity pneumonitis, then taper over weeks based on clinical and pulmonary function response. If HRCT shows usual interstitial pneumonia without exposure signal, initiate antifibrotic therapy such as nintedanib or pirfenidone and refer for lung transplant evaluation when advanced.

Try a free question

Core

A 58-year-old man has progressive dyspnea for 2 years. BP 130/80 mm Hg, HR 88/min, temp 36.8 C. HRCT shows basilar subpleural honeycombing with traction bronchiectasis and no relevant exposure history. What is the next best step in management?

Show answer and explanation

Answer: A. Start nintedanib therapy. Classic IPF with usual interstitial pneumonia pattern is treated with antifibrotic therapy to slow progression.

Why the other choices are tempting

  • B. No evidence suggests bacterial pneumonia as the main process.
  • C. Prolonged high-dose steroids are not standard first-line for stable IPF.
  • D. Observation alone misses disease-modifying treatment opportunity.
  • E. No findings indicate active tuberculosis.

Flashcards

Tap a card to flip it.

Which HRCT pattern is most characteristic of idiopathic pulmonary fibrosis?

Basal subpleural honeycombing with traction bronchiectasis is characteristic of usual interstitial pneumonia in IPF.

What history clue strongly favors hypersensitivity pneumonitis over IPF?

Respiratory symptoms linked to bird, mold, or farm antigen exposure that improve away from exposure favors HP.

Quick answers

What is the fastest way to tell Idiopathic pulmonary fibrosis from Hypersensitivity pneumonitis?

Clear antigen exposure history with BAL lymphocytosis favors hypersensitivity pneumonitis over idiopathic pulmonary fibrosis.

What is the key clue for Idiopathic pulmonary fibrosis?

Progressive exertional dyspnea with bibasilar crackles and usual interstitial pneumonia pattern on HRCT indicates idiopathic pulmonary fibrosis.

What is the key clue for Hypersensitivity pneumonitis?

Dyspnea and cough linked to bird or mold exposure with centrilobular nodules and ground-glass opacities suggests hypersensitivity pneumonitis.

What is the common trap with Idiopathic pulmonary fibrosis vs Hypersensitivity pneumonitis?

Both diseases can show restrictive physiology, so clinicians overcall IPF in exposed patients. The resolving clue is exposure-linked symptom fluctuation plus inflammatory imaging pattern rather than basal honeycombing.